Key statistics
On Tuesday, Atara Biotherapeutics Inc (AT20:FRA) closed at 9.25, 106.13% above the 52 week low of 4.49 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 9.25 |
Low | 9.25 |
Bid | -- |
Offer | -- |
Previous close | 9.25 |
Average volume | -- |
---|---|
Shares outstanding | 5.66m |
Free float | 4.41m |
P/E (TTM) | -- |
Market cap | 66.65m USD |
EPS (TTM) | -39.90 USD |
Data delayed at least 15 minutes, as of Jun 18 2024 16:28 BST.
More ▼
Press releases
- Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
- Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Atara Biotherapeutics Announces $36 Million Registered Direct Offering
More ▼